Spectral AI, Inc. (MDAIW) stock

MDAIWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as MDAI

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 0/30

$0.45−0.04 (-8.55%)

Close on Oct 30, 2026Market cap $49.24MP/E –Yield –

Spectral AI price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Spectral AI's price to sales ratio was 3.2× on Oct 19, 2026, against 2.0× a year earlier. Over the last 4 years it ranged from 0.8× to 6.0×, with a median of 1.9×.

Price to Sales Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Oct 19, 2026	3.2×	+1.5
2025	Dec 31, 2025	1.7×	−0.3
2024	Dec 31, 2024	1.9×	−0.1
2023	Dec 29, 2023	2.0×	–

Where these numbers come from

Parsed from the XBRL in Spectral AI's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is MDAIW.

Compare: MDAIW vs HYPR · MDAIW vs PROF · MDAIW vs BTCY · MDAIW vs SRTS · MDAIW vs SNOA

Revenue growth-44.1% · median 47.0%

Gross margin42.9% · median 51.4%

Operating margin-77.2% · median -75.7%

Net margin-65.5% · median -88.5%

Company	Revenue	Growth
SNOA	$21.92M	+47.0%
PROF	$19.09M	+61.2%
SRTS	$17.51M	-53.4%
HYPR	$16.54M	+53.2%
BTCY	$16.40M	+13.4%
MDAIW	$15.39M	-44.1%

Company

Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 65
Auditor: Forvis Mazars, LLP
SEC CIK: 1833498

Advertisement
300 × 250

Spectral AI price to sales ratio

Price to Sales Ratio at the end of each year

More Spectral AI figures